● Recruiting

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Condition: Endometrial Cancer · Sponsor: M.D. Anderson Cancer Center

PhasePhase 1

Planned participants21

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer. The safety and effects of this study treatment will also be studied

This description comes directly from the study's public registry record.

Talk to the study team

Pamela Soliman, MD · 713-745-2352 · psoliman@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05819892